Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous

QR Code

Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yashavanthi Mysore, Eva M. del Amo, Sirpa Loukovaara, Marja Hagström, Arto Urtti, Anu Kauppinen
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/78cc0357322842e3ad8e580c4944d9b4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
par: Yashavanthi Mysore, et autres
Publié: (2021)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
par: Sadaka A, et autres
Publié: (2016)

Proliferative vitreoretinopathy: current and emerging treatments
par: Sadaka A, et autres
Publié: (2012)

INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION
par: Karsh Gaurav, et autres
Publié: (2021)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
par: Marina G. Bubnova, et autres
Publié: (2021)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
par: Shun-Hua Chen, et autres
Publié: (2021)

Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
par: Tuuminen R, et autres
Publié: (2016)

Statins and Insulin Resistance
par: GM Sanvee, et autres
Publié: (2020)

Cerebrovascular Disease and Statins
par: Luis M. Beltrán Romero, et autres
Publié: (2021)

Adherence and prescription of statin therapy in primary prevention in primary care unit
par: Juraj Jug, et autres
Publié: (2021)

Treating statin-intolerant patients
par: Pigna G, et autres
Publié: (2011)

Statins in Non-alcoholic Steatohepatitis
par: Jose D. Torres-Peña, et autres
Publié: (2021)

Statins and diabetes: focus on pitavastatin
par: Soreiia A. Urazgildeeva
Publié: (2020)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
par: Thongtang N, et autres
Publié: (2020)

PREVENTIVE EFFECT OF LONG ACTING Β2-AGONISTS ON STATIN INDUCED MYOPATHIES
par: Abdullah Qamar, et autres
Publié: (2018)

Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review
par: Behzad Heidari, et autres
Publié: (2021)

Dashed line relaxing retinotomy in the management of retinal detachment with anterior proliferative vitreoretinopathy
par: Tsen CL, et autres
Publié: (2015)

Relaxing retinotomies and retinectomies in the management of retinal detachment with severe proliferative vitreoretinopathy (PVR)
par: Khaled AG Shalaby
Publié: (2010)

Epiretinal membrane and cystoid macular edema as predictive factors of recurrent proliferative vitreoretinopathy
par: Xu K, et autres
Publié: (2017)

Statins and diabetes mellitus: price of collaboration
par: Andrey Alexeevich Aleksandrov, et autres
Publié: (2012)

Statin use and risk of diabetes mellitus
par: Oksana Mikhailovna Drapkina, et autres
Publié: (2012)

Statins and risk of breast cancer recurrence
par: Sakellakis M, et autres
Publié: (2016)

Are statins beneficial for the treatment of pulmonary hypertension?
par: Lei Wang, et autres
Publié: (2017)

The potential effect of statins on rituximab immunotherapy.
par: Mark S Cragg
Publié: (2008)

Pleiotropic effects of statins: New evidences
par: Kaan Okyay
Publié: (2021)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
par: Muhiddin HS, et autres
Publié: (2020)

Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
par: Kaku Itoh, et autres
Publié: (2021)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
par: Jihaeng Im, et autres
Publié: (2021)

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006.
par: Mariam Molokhia, et autres
Publié: (2008)

Retinotomy with retinal turnover to remove subretinal membranes under direct visualization for proliferative vitreoretinopathy
par: Kimura M, et autres
Publié: (2012)

Upregulation of ASPP2 expression alleviates the development of proliferative vitreoretinopathy in a rat model
par: Yan-Kun Yue, et autres
Publié: (2021)

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
par: Ani Korhonen, et autres
Publié: (2021)

Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis
par: Chen Chen, et autres
Publié: (2021)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
par: Yu-Cheng Kao, et autres
Publié: (2021)

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy
par: Yuichi Ikegami, et autres
Publié: (2018)

Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy
par: Tlucek PS, et autres
Publié: (2013)

SIMULTANEOUS QUANTITATION OF MOXIFLOXACIN AND STATINS INAPI BY RP-HPLC
par: Qamar,Fatima, et autres
Publié: (2019)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
par: Tracey M Ellimuttil, et autres
Publié: (2021)

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
par: Cormac McCarthy, et autres
Publié: (2018)

Harnessing Therapeutic Potentials of Statins Using Nanofibrous Carriers
par: Mahshid Ataei, et autres
Publié: (2021)